FDA Homepage
-
-
Advancing toward the goal of global approval for generic drugs
- FDA proposes critical first steps to harmonize global standards for generic drugs
- Advancing toward the goal of global approval for generic drugs
-
News & Events
- November 20, 2018 - FDA warns marketers of products labeled as dietary supplements that contain tianeptine for making unproven claims to treat serious conditions, including opioid use disorder
- November 20, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D. and Jeff Shuren, M.D., Director of the Center for Devices and Radiological Health, on FDA’s updates to Medical Device Safety Action Plan to enhance post-market safety
- November 20, 2018 - FDA approves first treatment specifically for patients with rare and life-threatening type of immune disease
Newsroom
Recent Consumer Updates
Browse by Audience
-
For Consumers
Updates and information for staying safe and healthy -
For Patients
Learn about other treatments, drug/device approvals, public meetings and more -
For Health Professionals
Medical product safety information, adverse event/problem reporting and more -
For Scientists & Researchers
NCTR, pediatrics, clinical trials, Critical Path Initiative, foods and veterinary medicine research, and more -
For Industry
Guidance, registration and listing, pay user fees, import programs and more
FDA Voices:
Perspectives from FDA Experts
Page Last Updated: 11/20/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English